{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:17:56Z","timestamp":1760188676686},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1987,9]]},"DOI":"10.1007\/bf02206836","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T19:13:39Z","timestamp":1128539619000},"page":"378-383","source":"Crossref","is-referenced-by-count":4,"title":["Sulphasalazine in arthritis \u2014 an old drug rediscovered"],"prefix":"10.1007","volume":"6","author":[{"given":"A. J.","family":"Taggart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02206836_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","volume":"110","author":"N. Svartz","year":"1942","unstructured":"Svartz, N. Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 1942, 110, 577\u201398.","journal-title":"Acta Med Scand"},{"key":"BF02206836_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/ard.8.3.226","volume":"8","author":"R.J.G. Sinclair","year":"1948","unstructured":"Sinclair, R.J.G., Duthie, J.J.R. Salazopyrin in the treatment of rheumatoid arthritis. Ann Rheum Dis 1948, 8, 226\u201331.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR3","first-page":"476","volume":"73","author":"W.C. Kuzell","year":"1950","unstructured":"Kuzell, W.C., Gardner, G.M. Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis. Calif Med 1950, 73, 476\u201380.","journal-title":"Calif Med"},{"key":"BF02206836_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(65)90972-4","volume":"1","author":"J.J. Misiewicz","year":"1965","unstructured":"Misiewicz, J.J., Lennard-Jones, J.E., Connell, A.M., Baron, J.H., Avery Jones, F. Controlled trial of sulphasalazine in ulcerative colitis. Lancet 1965, 1, 185\u20138.","journal-title":"Lancet"},{"key":"BF02206836_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/rheumatology\/15.3.230","volume":"15","author":"B. McConkey","year":"1976","unstructured":"McConkey, B., Davies, P., Crockson, R.A., Crockson, A.P., Butler, M., Constable, T.J. Dapsone in rheumatoid arthritis. Rheumatol Rehabil 1976, 15, 230\u20134.","journal-title":"Rheumatol Rehabil"},{"key":"BF02206836_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF01968673","volume":"8","author":"B. McConkey","year":"1978","unstructured":"McConkey, B., Amos, R.S., Butler, E.P., Crockson, R.A., Crockson, A.P., Walsh, L. Salazopyrin in rheumatoid arthritis. Agents Actions 1978, 8, 438\u201341.","journal-title":"Agents Actions"},{"key":"BF02206836_CR7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/bmj.287.6399.1099","volume":"287","author":"V.C. Neumann","year":"1983","unstructured":"Neumann, V.C., Grindulis, K.A., Hubball, S., McConkey, B., Wright, V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham Trial. Br Med J 1983, 287, 1089\u20131102.","journal-title":"Br Med J"},{"key":"BF02206836_CR8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/bmj.287.6399.1102","volume":"287","author":"T. Pullar","year":"1983","unstructured":"Pullar, T., Hunter, J.A., Capell, H.A. Sulphasalazine in rheumatoid arthritis: a double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983, 287, 1102\u20134.","journal-title":"Br Med J"},{"key":"BF02206836_CR9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.285.6347.1012","volume":"285","author":"M.J. Dew","year":"1982","unstructured":"Dew, M.J., Hughes, P., Harries, A.D., Williams, G., Evans, B.K., Rhodes, J. Mintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J 1982, 285, 1012.","journal-title":"Br Med J"},{"key":"BF02206836_CR10","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/bmj.290.6481.1535","volume":"290","author":"T. Pullar","year":"1985","unstructured":"Pullar, T., Hunter, J.A., Capell, H.A. Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J 1985, 290, 1535\u20138.","journal-title":"Br Med J"},{"key":"BF02206836_CR11","first-page":"285","volume":"13","author":"V.C. Neumann","year":"1986","unstructured":"Neumann, V.C., Taggart, A.J., Le Gallez, P., Astbury, C., Hill, J., Bird, H.A. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 1986, 13, 285\u20137.","journal-title":"J Rheumatol"},{"key":"BF02206836_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/25.3.285","volume":"25","author":"G. Ash","year":"1986","unstructured":"Ash, G., Baker, R., Rajapakse, C., Swinson, D.R. Study of sulphamethoxazole in rheumatoid arthritis. Br J Rheumatol 1986, 25, 285\u20137.","journal-title":"Br J Rheumatol"},{"key":"BF02206836_CR13","unstructured":"Astbury, C., Hill, J., Bird, H.A. Co-trimoxazole (CTZ) in rheumatoid arthritis. Br J Rheumatol 1986, 25 Suppl 2, Abstract 46."},{"key":"BF02206836_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/rheumatology\/24.3.269","volume":"24","author":"T. Pullar","year":"1985","unstructured":"Pullar, T., Hunter, J.A., Capell, H.A. Sulphasala-zine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol 1985, 24, 269\u201376.","journal-title":"Br J Rheumatol"},{"key":"BF02206836_CR15","first-page":"287","volume":"12","author":"H. Mielants","year":"1985","unstructured":"Mielants, H., Veys, E.M. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulphasalazine (salazopyrin) in HLA-B27 related reactive arthritis. J Rheumatol 1985, 12, 287\u201393.","journal-title":"J Rheumatol"},{"key":"BF02206836_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02030973","volume":"5","author":"H. Mielants","year":"1986","unstructured":"Mielants, H., Veys, E.M., Joos, R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986, 5, 80\u201383.","journal-title":"Clin Rheumatol"},{"key":"BF02206836_CR17","unstructured":"Peliskova, Z., Vacha, J., Trnavsky, K. Sulphasalazine in reactive arthritis: an open trial. Br J Rheumatol 1986, 25 Suppl 2, Abstract 49."},{"key":"BF02206836_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.45.5.396","volume":"45","author":"N. Feltelius","year":"1986","unstructured":"Feltelius, N., Hallgren, R. Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 1986, 45, 396\u20139.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/bmj.293.6552.911","volume":"293","author":"M. Dougados","year":"1986","unstructured":"Dougados, M., Boumier, P., Amor, B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br Med J 1986, 293, 911\u20134.","journal-title":"Br Med J"},{"key":"BF02206836_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197309062891001","volume":"289","author":"K.M. Das","year":"1973","unstructured":"Das, K.M., Eastwood, M.A., McManus, J.P.A., Sircus, W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973, 289, 491\u20135.","journal-title":"N Engl J Med"},{"key":"BF02206836_CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.44.12.831","volume":"44","author":"T. Pullar","year":"1985","unstructured":"Pullar, T., Hunter, J.A., Capell, H.A., Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis 1985, 44, 831\u20137.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard.45.2.139","volume":"45","author":"D.E. Bax","year":"1986","unstructured":"Bax, D.E., Amos, R.S. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Ann Rheum Dis 1986, 45, 139\u201340.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.44.11.798","volume":"44","author":"M. Farr","year":"1985","unstructured":"Farr, M., Symmons, D.P.M., Bacon, P.A. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine. Ann Rheum Dis 1985, 44, 798\u2013800.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2222.1974.tb01361.x","volume":"4","author":"P. Thomas","year":"1974","unstructured":"Thomas, P., Seaton, A., Edwards, J. Respiratory disease due to sulphasalazine. Clin Allergy 1974, 4, 41\u20137.","journal-title":"Clin Allergy"},{"key":"BF02206836_CR25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01255610","volume":"19","author":"R.J. Raforth","year":"1974","unstructured":"Raforth, R.J. Systemic granulomatous reaction due to salicylsulfapyridine (azulfidine) in a patient with Crohn's disease. Am J Dig Dis 1974, 19, 465\u20139.","journal-title":"Am J Dig Dis"},{"key":"BF02206836_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/rheumatology\/23.3.232-a","volume":"23","author":"A.J. Crisp","year":"1984","unstructured":"Crisp, A.J. Sulphasalazine in rheumatoid arthritis (letter). Br J Rheumatol 1984, 23, 232.","journal-title":"Br J Rheumatol"},{"key":"BF02206836_CR27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0015-0282(16)44000-8","volume":"31","author":"A. Toth","year":"1979","unstructured":"Toth, A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979, 31, 538\u201340.","journal-title":"Fertil Steril"},{"key":"BF02206836_CR28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(79)90292-7","volume":"ii","author":"A.J. Levi","year":"1979","unstructured":"Levi, A.J., Fischer, A.M., Hughes, L., Hendry, W.F. Male infertility due to sulphasalazine. Lancet 1979 ii, 276\u20138.","journal-title":"Lancet"},{"key":"BF02206836_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2605.1986.tb00866.x","volume":"9","author":"A. Givercman","year":"1986","unstructured":"Givercman, A., Skakkeboek, N.E. The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. Int J Androl 1986, 9, 38\u201352.","journal-title":"Int J Androl"},{"key":"BF02206836_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/03009748509100404","volume":"14","author":"K. Grindulis","year":"1985","unstructured":"Grindulis, K., McConkey, B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis? Scand J Rheumatol 1985, 14, 265\u201370.","journal-title":"Scand J Rheumatol"},{"key":"BF02206836_CR31","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.289.6448.798","volume":"289","author":"J.E.W. Pette Van de","year":"1984","unstructured":"Van de Pette, J.E.W., Cunnah, D.T.E., Shallcross, T.M. Bone marrow necrosis after treatment with sulphasalazine. Br Med J 1984, 289, 798.","journal-title":"Br Med J"},{"key":"BF02206836_CR32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bmj.293.6544.420","volume":"293","author":"R.S. Amos","year":"1986","unstructured":"Amos, R.S., Pullar, T., Bax, D., Situnayake, D., Capell, H.A., McConkey, B. Sulphasalazine for rheumatoid arthritis: Toxicity in 774 patients monitored for one to eleven years. Br Med J 1986, 293, 420\u20132.","journal-title":"Br Med J"},{"key":"BF02206836_CR33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.44.3.194","volume":"44","author":"D.E. Bax","year":"1985","unstructured":"Bax, D.E., Amos, R.S. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis 1985, 44, 194\u20138.","journal-title":"Ann Rheum Dis"},{"key":"BF02206836_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.292.6518.431","volume":"292","author":"V. Wright","year":"1986","unstructured":"Wright, V. Regular Review: treatment of severe rheumatoid arthritis. Br Med J 1986, 292, 431\u20132.","journal-title":"Br Med J"},{"key":"BF02206836_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","volume":"10","author":"U. Klotz","year":"1985","unstructured":"Klotz, U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinetics 1985, 10, 285\u2013302.","journal-title":"Clin Pharmacokinetics"},{"key":"BF02206836_CR36","first-page":"392","volume":"ii","author":"A.K. Azad Khan","year":"1977","unstructured":"Azad Khan, A.K., Piris, J., Truelove, S.C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977, ii, 392\u20135.","journal-title":"Lancet"},{"key":"BF02206836_CR37","doi-asserted-by":"crossref","unstructured":"Taggart, A.J., McDermott, B., Delargy, M., El-born, S., Forbes, J., Roberts, S.D., Ahnfelt, N-O. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis. Scand J Rheumatol 1987, in press.","DOI":"10.3109\/03009748709096719"},{"key":"BF02206836_CR38","series-title":"Clinical Pharmacology of Skin Disease","first-page":"217","volume-title":"Sulfones and sulphapyridine","year":"1984","unstructured":"Bickers, D.R., Hazen, P.G., Lynch, W.S. (Eds). Sulfones and sulphapyridine. In: Clinical Pharmacology of Skin Disease. London: Churchill Livingstone, 1984, 217\u201334."},{"key":"BF02206836_CR39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.0954-6820.1968.tb02478.x","volume":"184","author":"B. Olhagen","year":"1968","unstructured":"Olhagen, B., Mansson, I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 1968, 184, 395\u2013402.","journal-title":"Acta Med Scand"},{"key":"BF02206836_CR40","unstructured":"Shinebaum, R., Neumann, V., Wright, V., Cooke, E.M. Comparison of faecal flora of patients with rheumatoid arthritis and controls. J Med Microbiol 1984, 18, Abstract No. IV."},{"key":"BF02206836_CR41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.15.12.960","volume":"15","author":"B. West","year":"1974","unstructured":"West, B., Lendrum, R., Hill, M.J., Walker, G. Effects of sulphasalazine (salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 1974, 15, 960\u20135.","journal-title":"Gut"},{"key":"BF02206836_CR42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0140-6736(84)90163-6","volume":"1","author":"H. Mielants","year":"1984","unstructured":"Mielants, H., Veys, E.M. Inflammation of the ileum in patients with B27-positive reactive arthritis. Lancet 1984, 1, 288.","journal-title":"Lancet"},{"key":"BF02206836_CR43","first-page":"1538","volume":"310","author":"H. Mielants","year":"1984","unstructured":"Mielants, H., Veys, E.M. Reiter's syndrome and reactive arthritis. New Engl J Med 1984, 310, 1538.","journal-title":"New Engl J Med"},{"key":"BF02206836_CR44","unstructured":"Mielants, H., Veys, E.M., Cuvelier, C. et al. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol 1985, 294\u2013298."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02206836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02206836\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02206836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T18:35:27Z","timestamp":1557858927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02206836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["BF02206836"],"URL":"https:\/\/doi.org\/10.1007\/bf02206836","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}